Biopol Chemicals
- P/E
- Not shown: the earnings on file are not confirmed as this company’s by the latest update
Key Fundamentals
SMEChemicals & PetrochemicalsChemicalsPrice-based figures as of · TTM
- ROCE
- 38.20%
- Debt to Equity
- 0.57
- EPS (TTM)
- —
- Book Value
- ₹46.20
- Market Cap
- —
- P/E (TTM)
- Not shown: the earnings on file are not confirmed as this company’s by the latest update
- P/B
- 0.95
- ROE
- 38.20%
- Dividend Yield
- 0.00%
- EBITDA
- ₹13.70 Cr
- 52W High
- ₹133.75
- 52W Low
- ₹39.50
- Volume
- 0
Peer Comparison
Chemicals › Specialty Chemicals
| ₹1,510.20 | 58.04 | ₹1,54,107 Cr | 13.72 | 1.42% | 23.90% | 31.00% | ₹15,399 Cr | ₹2,677 Cr | |
| ₹4,613.30 | 83.76 | ₹49,073 Cr | 6.04 | 0.07% | 7.82% | 9.64% | ₹5,303 Cr | ₹600 Cr | |
| ₹8,785.00 | 57.03 | ₹44,060 Cr | 10.10 | 0.09% | 19.60% | 21.00% | ₹3,634 Cr | ₹789 Cr | |
| ₹1,578.40 | 27.48 | ₹20,919 Cr | 3.32 | 0.49% | 9.82% | 11.40% | ₹8,575 Cr | ₹784 Cr | |
| ₹1,540.70 | 86.90 | ₹20,030 Cr | 7.88 | 0.00% | 9.66% | 11.90% | ₹1,231 Cr | ₹235 Cr | |
| ₹447.55 | 30.57 | ₹15,838 Cr | 2.59 | 0.23% | 7.13% | 6.86% | ₹9,010 Cr | ₹531 Cr | |
| ₹5,156.50 | 19.67 | ₹14,827 Cr | 2.31 | 0.59% | 11.50% | 14.90% | ₹6,969 Cr | ₹788 Cr | |
| Biopol Chemicals (this company) | ₹43.75 | — | ₹49 Cr | 0.95 | 0.00% | 38.20% | 38.20% | ₹50 Cr | ₹6 Cr |
| Median 8 companies | ₹1,559.55 | 57.03 | ₹20,474 Cr | 4.68 | 0.16% | 10.66% | 13.40% | ₹6,136 Cr | ₹692 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 9 | 8 | 2 |
| Oscillators | Bullish | 1 | 6 | 2 |
| Moving Averages | Strong Bearish | 8 | 2 | 0 |
Oscillators
Bullish
Overall
Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 39.55
- Neutral
- MACD (12,26,9)
- −2.77
- Bullish
- SMA (50)
- 52.73
- Bearish
- SMA (200)
- —
- Neutral
As of
Growth Rate
From the financial statements below. 1Y: fiscal year to Mar 2025 against Mar 2024.
Revenue
| 1Y | +93.27% |
|---|
Net profit
| 1Y | +46.62% |
|---|
Operating cash flow
| 1Y | Outflow narrowed by ₹4.10 Cr |
|---|
Operating margin· change in pp
| 1Y | −4.12 pp |
|---|
Trailing twelve months: No quarterly results are reported.
Revenue by year
| Mar 2024 | ₹25.42 Cr |
|---|---|
| Mar 2025 | ₹49.13 Cr |
Net profit by year
| Mar 2024 | ₹2.96 Cr |
|---|---|
| Mar 2025 | ₹4.34 Cr |
Not shown: Quarterly Results. Not this company's figures: left behind by an earlier update and not confirmed by the latest one.
Profit & Loss
₹ Cr| Particulars | Mar 2024 | Mar 2025 |
|---|---|---|
| Sales | 25.42 | 49.13 |
| Expenses | 20.99 | 42.59 |
| Operating Profit | 4.43 | 6.54 |
| OPM % | 17.43% | 13.31% |
| Other Income | 0 | 0.02 |
| Interest | 0.39 | 0.68 |
| Depreciation | 0.08 | 0.07 |
| PBT | 3.96 | 5.81 |
| Tax % | 25.25% | 25.13% |
| Net Profit | 2.96 | 4.34 |
| EPS (₹) | 3.74 | 5.49 |
| Div. Payout % | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2024 | Mar 2025 |
|---|---|---|
| Equity Capital | 7.91 | 7.91 |
| Reserves | 1.29 | 5.63 |
| Borrowings | 3.58 | 7.68 |
| Other Liabilities | 4.77 | 10.26 |
| Total Liabilities | 17.55 | 31.48 |
| Fixed Assets | 0.21 | 0.23 |
| CWIP | 0.06 | 0 |
| Investments | 0 | 0 |
| Other Assets | 17.28 | 31.25 |
| Total Assets | 17.55 | 31.48 |
Cash Flow
₹ Cr| Particulars | Mar 2024 | Mar 2025 |
|---|---|---|
| Operating | −6.44 | −2.34 |
| Investing | −0.64 | −0.02 |
| Financing | 7.14 | 3.43 |
| Net Cash Flow | 0.06 | 1.07 |
Ratios
| Particulars | Mar 2024 | Mar 2025 |
|---|---|---|
| Debtor Days | 145 | 124 |
| Inventory Days | 121 | 107 |
| Days Payable | 77.9 | 77.77 |
| Cash Conversion Cycle | 189 | 153 |
| Working Capital Days | 127 | 95.17 |
| ROCE % | — | 38.18% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Biopol Chemicals insights
28 extracted metrics across FY22–FY26.
Documents
- 12 Jun 2026
- 11 Jun 2026
- 11 Jun 2026
Frequently Asked Questions about Biopol Chemicals
Where is Biopol Chemicals (BIOPOL) listed?
Which sector does Biopol Chemicals belong to?
What is the 52-week high and low of Biopol Chemicals?
What is the Return on Equity (ROE) of Biopol Chemicals?
Company Information
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/760945.md for Biopol Chemicals: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.